Suchergebnisse - "Onoue, Satomi"

PubPharm (11)

1

Protective effects of tranilast on experimental colitis in rats

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2017

von Seto, Y. | Kato, K. | Tsukada, R. | +5

2

Development of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying : In Vitro Characterization and Pharmacokinetic Profiling

enthalten in: Pharmaceutical research | 2016

von Seto, Y. | Suzuki, G. | Leung, S. | +2

3

In vitro/in vivo characterization of nanocrystalline formulation of tranilast with improved dissolution and hepatoprotective properties

enthalten in: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | 2013

von Onoue, S. | Yamamoto, K. | Kawabata, Y. | +1

4

Chemical synthesis and formulation design of a PEGylated vasoactive intestinal peptide derivative with improved metabolic stability

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2013

von Onoue, S. | Matsui, T. | Kato, M. | +6

5

Inhalable powder formulation of pirfenidone with reduced phototoxic risk for treatment of pulmonary fibrosis

enthalten in: Pharmaceutical research | 2013

von Onoue, S. | Seto, Y. | Kato, M. | +3

6

Development of cyclosporine A-loaded dry-emulsion formulation using highly purified glycerol monooleate for safe inhalation therapy

enthalten in: International journal of pharmaceutics | 2013

von Sato, H. | Ogawa, K. | Kojo, Y. | +4

7

Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats

enthalten in: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | 2012

von Onoue, S. | Sato, H. | Ogawa, K. | +6

8

Formulation design and in vivo evaluation of dry powder inhalation system of new vasoactive intestinal peptide derivative ([R(15, 20, 21), L(17), A(24,25), des-N(28)]-VIP-GRR) in experimental asthma/COPD model rats

enthalten in: International journal of pharmaceutics | 2011

von Onoue, S. | Aoki, Y. | Matsui, T. | +4

9

Inhalable powder formulation of vasoactive intestinal peptide derivative, [R15,20,21, L17]-VIP-GRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2010

von Onoue, S. | Misaka, S. | Aoki, Y. | +5

10

Inhalable powder formulation of a stabilized vasoactive intestinal peptide (VIP) derivative : anti-inflammatory effect in experimental asthmatic rats

enthalten in: Peptides | 2010

von Misaka, S. | Aoki, Y. | Karaki, S. | +4